Ileal calprotectin levels predict colon endoscopic activity in patients with inflammatory bowel disease

被引：0
|
作者：
Sundararajan, Subha
Schamberg, Neal
Gonzalez, Stevan
Scherl, Ellen
Bosworth, Brian
机构：
[1] New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Med, Div Gastroenterol & Hepatol, New York, NY USA
[2] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷
关键词：
D O I：
10.14309/00000434-200809001-01156
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1156
引用
收藏
页码：S452 / S452
页数：1
相关论文
共 50 条
  • [21] QUALITY OF LIFE, FECAL CALPROTECTIN AND ENDOSCOPIC DISEASE ACTIVITY: A STUDY OF CORRELATION IN INFLAMMATORY BOWEL DISEASE.
    Magalhaes, Rui S.
    Xavier, Sofia
    de Castro, Francisca Dias
    Goncalves, Tiago Curdia
    Rosa, Bruno
    Moreira, Maria Joao
    Cotter, Jose
    GASTROENTEROLOGY, 2020, 158 (06) : S656 - S656
  • [22] Fecal leukocyte esterase level can predict endoscopic activity for Inflammatory Bowel Disease patients
    Weng, M. T.
    Tsai, F. P.
    Tung, C. C.
    Wu, H. Y.
    Chen, Z. C.
    Wei, S. C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I652 - I652
  • [23] Endoscopic evaluation for colon cancer and dysplasia in patients with inflammatory bowel disease
    Shergill, Amandeep K.
    Farraye, Francis A.
    TECHNIQUES IN GASTROINTESTINAL ENDOSCOPY, 2016, 18 (03) : 145 - 151
  • [24] Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease
    Bourgonje, Arno R.
    Gabriels, Ruben Y.
    de Borst, Martin H.
    Bulthuis, Marian L. C.
    Faber, Klaas Nico
    van Goor, Harry
    Dijkstra, Gerard
    ANTIOXIDANTS, 2019, 8 (09)
  • [25] Minimal additional benefits in adding faecal haemoglobin to faecal calprotectin in predicting endoscopic disease activity in patients with inflammatory bowel disease
    Mak, L. -Y.
    Chen, L.
    Tong, T.
    Lau, S.
    Leung, W. -K.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S67 - S68
  • [26] Association between Serum Calprotectin Expression and Disease Activity in Patients with Inflammatory Bowel Disease
    Chen, R. D.
    Hu, Yun Yun
    Chen, Qian
    Xu, Han
    Qian, M. J.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 83 : 12 - 17
  • [27] Fecal Calprotectin Is a Useful Marker for Disease Activity in Pediatric Patients with Inflammatory Bowel Disease
    Tomoki Aomatsu
    Atsushi Yoden
    Kyoichi Matsumoto
    Emi Kimura
    Keisuke Inoue
    Akira Andoh
    Hiroshi Tamai
    Digestive Diseases and Sciences, 2011, 56 : 2372 - 2377
  • [28] Salivary Calprotectin is Not a Useful Biomarker to Monitor Disease Activity in Patients with Inflammatory Bowel Disease
    Bos, Vincent
    Crouwel, Femke
    Waaijenberg, Petra
    Bouma, Gerd
    Duijvestein, Marjolijn
    Buiter, Hans J. C.
    Brand, Henk S.
    Hamer, Henrike M.
    De Boer, Nanne K.
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2022, 31 (03) : 283 - 289
  • [29] Fecal Calprotectin Is a Useful Marker for Disease Activity in Pediatric Patients with Inflammatory Bowel Disease
    Aomatsu, Tomoki
    Yoden, Atsushi
    Matsumoto, Kyoichi
    Kimura, Emi
    Inoue, Keisuke
    Andoh, Akira
    Tamai, Hiroshi
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2372 - 2377
  • [30] Endoscopic Disease Activity and Biologic Therapy Predict Quality of Bowel Preparation for Colonoscopies in Inflammatory Bowel Disease
    Shenoy, Vinayak
    Kumar, Anand
    Buckley, Megan C.
    Durbin, Laura
    Mackey, James
    Mone, Anjali
    Swaminath, Arun
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S382 - S382
12345